Novel Strategy Using Tryptic Peptide Immunoaffinity-Based LC–MS/MS to Quantify Denosumab in Monkey Serum

Abstract

This approach accelerated the quantification, reduced the costs and provided an alternative in case of lacking the special antigen to denosumab or a RANKL-biotinylated reagent.